I'm not surprised that Novo Nordisk is taking a hit from Trump's weight loss drug price push
... I mean, come on, $1,000 a month for Ozempic? That's just crazy talk
. But at the same time, you gotta wonder if they were really expecting sales to tank this badly
. I get that they're trying to be more competitive and whatnot, but slashing prices by like 70% is no joke
.
It's interesting to see Eli Lilly taking a different approach though
... maybe their strategy will pay off in the end? And hey, if Wegovy keeps going strong, Novo Nordisk might just bounce back from this
. Still, it's clear that these big pharma companies need to be more careful with their pricing and investment plans
.
(GIF: a person running into a wall)
(Meme: a cartoon character flexing and smiling, with a price tag on their shirt)
(GIF: a person trying to blend in with a crowd)
. Novo Nordisk is taking a hit from slashed prices, but Eli Lilly seems to be dodging the bullet 